Skip to Content
MilliporeSigma

59164

SUPELCOSIL™ LC-18-DB (5 µm) HPLC Columns

L × I.D. 30 cm × 4 mm, HPLC Column

Slide 1 of 1
Sign In to View Organizational & Contract Pricing.

Select a Size

1 EA

$1,080.00

$1,080.00

Available to ship TODAYDetails

About This Item

UNSPSC Code:
41115700
eCl@ss:
32110501
NACRES:
NB.21

Key Documents

View All Documentation

Skip To

Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

SUPELCOSIL™ LC-18-DB HPLC Column, 5 μm particle size, L × I.D. 30 cm × 4 mm

agency

suitable for USP L1

feature

endcapped

manufacturer/tradename

SUPELCOSIL™

extent of labeling

11.0% Carbon loading

parameter

0-70 °C temperature
400 bar pressure (5801 psi)

technique(s)

HPLC: suitable

L × I.D.

30 cm × 4 mm

surface area

170 m2/g

surface coverage

surface coverage 3.1 μmol/m2

matrix

silica gel, spherical particle platform

matrix active group

C18 (octadecyl) phase

particle size

5 μm

pore size

120 Å

application(s)

food and beverages

separation technique

reversed phase

Quality Level

100

Looking for similar products? Visit Product Comparison Guide

Related Categories

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
583455834858993
Supelco

Supelco

59164

SUPELCOSIL™ LC-18-DB HPLC Column

SUPELCOSIL™ LC-18-DB HPLC Column 5 μm particle size, L × I.D. 5 cm × 4.6 mm

Supelco

58345

SUPELCOSIL™ LC-18-DB HPLC Column

SUPELCOSIL™ LC-18-DB HPLC Column 5 μm particle size, L × I.D. 15 cm × 4.6 mm

Supelco

58348

SUPELCOSIL™ LC-18-DB HPLC Column

SUPELCOSIL™ LC-18-DB HPLC Column 3 μm particle size, L × I.D. 15 cm × 4.6 mm

Supelco

58993

SUPELCOSIL™ LC-18-DB HPLC Column

particle size

5 μm

particle size

5 μm

particle size

5 μm

particle size

3 μm

L × I.D.

30 cm × 4 mm

L × I.D.

5 cm × 4.6 mm

L × I.D.

15 cm × 4.6 mm

L × I.D.

15 cm × 4.6 mm

separation technique

reversed phase

separation technique

reversed phase

separation technique

reversed phase

separation technique

reversed phase

matrix active group

C18 (octadecyl) phase

matrix active group

C18 (octadecyl) phase

matrix active group

C18 (octadecyl) phase

matrix active group

C18 (octadecyl) phase

technique(s)

HPLC: suitable

technique(s)

HPLC: suitable

technique(s)

HPLC: suitable

technique(s)

HPLC: suitable

pore size

120 Å

pore size

120 Å

pore size

120 Å

pore size

120 Å

General description

SUPELCOSIL LC-DB phases are specially deactivated for basic compounds. These columns provide shorter retention, better peak shape, and higher efficiency for organic bases than can be obtained on other Type A silica reversed-phase columns.

Other Notes

Discover LiChropur reagents ideal for HPLC or LC-MS analysis

Legal Information

SUPELCOSIL is a trademark of Sigma-Aldrich Co. LLC

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
299292-06
299292-05
299292-04
299292-03
299292-02

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

E Terjéki et al.
Journal of pharmaceutical and biomedical analysis, 24(5-6), 913-920 (2001-03-15)
RGH-1756 (1-(2-methoxy-phenyl)-4-(4-[4-(6-imidazo[2,1-b]-thiazolyl)-phenoxy]-butyl)-piperazine dimethansulphonate) is a novel atypical antipsychotic candidate of Gedeon Richter Ltd. A new HPLC method has been developed and validated for the quantitative determination of RGH-1756 in dog and rat plasma. The compound and the internal standard are
J S Patrick et al.
Analytical biochemistry, 199(1), 125-131 (1991-11-15)
A rapid, isocratic method for the determination of tryptophan in Escherichia coli fermentation broths by reversed-phase HPLC is described. Tryptophan can be measured in fermentations containing either chemically defined media or media with hydrolyzed protein supplements. The procedure was rugged
Xinghua Sun et al.
Anticancer research, 25(1A), 59-62 (2005-04-09)
A rapid, sensitive and specific high-performance liquid chromatographic (HPLC) method for the separation and quantification of L-methionine in plasma has been developed. After derivatization of plasma amino acids with o-phthalaldehyde (OPA), a 50 microl sample was loaded on a reversed-phase
O Majid et al.
Therapeutic drug monitoring, 23(2), 163-168 (2001-04-11)
Recipients of organ transplants remain particularly dependent on prednisolone as part of their maintenance immunosuppression. Despite this, the pharmacokinetics of prednisolone have never been fully characterized in these patients, and consequently dosing remains empirical. Accurate monitoring of prednisolone, its primary
S L Bramer et al.
Journal of pharmaceutical and biomedical analysis, 26(4), 637-650 (2001-08-23)
An LC/MS/MS method for the simultaneous determination of cilostazol, a quinolinone derivative, and three active metabolites, OPC-13015, OPC-13213, and OPC-13217, in human plasma was developed and validated. Cilostazol, its metabolites, and the internal standard, OPC-3930 were extracted from human plasma
View All Related Papers

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service